Genentech clinical trials. Improving patients’ li...

  • Genentech clinical trials. Improving patients’ lives is what we strive to do. It covers the Vascular Malformations pipeline drug profiles, including clinical and nonclinical stage products. This is a first-in-human Phase I/II, open-label, multicenter, dose-escalation and expansion study de Access the phase 3 registrational clinical trial for giredestrant combined with CDK4/6 inhibitor (palbociclib, ribociclib or abemaciclib) as first-line treatme This extension trial aims to test the long-term safety of astegolimab in combination with standard of care COPD treatment. Photos of patients who have benefited from Genentech medicines are displayed around Genentech's campus and serve as daily inspiration for employees. 2. For a comprehensive overview of our full development portfolio or all actively recruiting Phase 3 trials, please visit genentech-clinicaltrials. Meghan Mckenzie Work Director of Health Equity and Clinical Research at Genentech in November 2024 to Present Principal Inclusion, Patient Inclusion and Health Equity in Chief Diversity Office at Genentech in May 2020 to November 2024 Clinical Program Director at Genentech in October 2016 to April 2020 Sr. This program will explore the partnerships and strategies required to design and execute effective clinical trials. This study aims to explore the safety, tolerability, cellular kinetics, and pharmacodynami Find out more about the clinical trial for Lymphoma. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) provides an update that the United States Food and Drug Administration (U. Find out more about the clinical trial for Chronic Obstructive Pulmonary Disease (COPD). Joining Genentech means embracing a shared identity as a changemaker. About Genentech in Breast Cancer Genentech has been advancing breast cancer research for more than 30 years with the goal of helping as many people with the disease as possible. To date, 22 companies have tested 30 anti-TIGIT candidates in 220 clinical trials, recruiting Clinical Trial Information Clinical trials are research studies that are designed to determine if a medicine is safe and effective for patients. FDA) has placed the fenebrutinib multiple sclerosis (MS) clinical development program on partial clinical hold in the U. We use virtual technology to design, approve and enroll clinical trials faster than ever before, leading to accelerated timelines and efficiencies for inclusive research across our portfolio. Learn about clinical trials and early access programs for Genentech medicines. Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most complex health problems. At Genentech, we value all capabilites and experiences. 9 Last year, Roche subsidiary Genentech terminated more posts across its operations than had previously been thought. For half a century, Genentech's passion for science has driven us to explore uncharted territory, leading to groundbreaking discoveries that have fundamentally changed the lives of patients and reduced the burden of complex health challenges on society. Food and Drug Administration has accepted the company’ s New Drug Application for giredestrant, an investigational oral Find an online library of Genentech medical information including clinical trial data and product information for specific therapeutic areas with interactive search bar. All new drugs must be tested in clinical trials before they can be given to patients. This study will evaluate the efficacy and safety of astegolima What is a clinical trial? What is a clinical trial ? Clinical trials are medical research studies that involve people. Roche in clinical trials Why does Roche conduct clinical trials? Clinical trials are an essential part of developing new drugs. 2-4 Access the clinical trial testing the efficacy and safety of continued etrolizumab treatment in patients with moderate to severe Ulcerative colitis (UC) previo Find out more about the clinical trial for Chronic Obstructive Pulmonary Disease (COPD). Feb 9, 2026 · This is a first-in-human Phase I/II, open-label, multicenter, dose-escalation and expansion study designed to evaluate the safety, pharmacokinetics, and preliminary activity of GDC-7035 as a single agent and in combination with other anti-cancer therapies in participants with advanced or metastatic solid tumors that harbor the KRAS G12D mutation. For nearly 50 years, we have pursued groundbreaking science to discover and develop innovative medicines for people facing serious and life-threatening diseases. How does the GB43374 clinical trial work? This clinical trial is recruiting people with COPD. WELCOME TO GENENTECH CLINICAL TRIALS Genentech Clinical Trials is a resource with information in clear and understandable language about clinical trials where Roche/Genentech is doing or supporting research. United Kingdom, Germany, Netherlands Genentech, Inc. Find more information about the Genentech Clinical Trials website and investigator-initiated studies where Roche is a supporting collaborator. com. Clinical Trials at the Summit (CTS) 2025 brings together a diverse group of experts from around the world to discuss ongoing clinical trials and the latest data, all with the goal of achieving advances in vitreoretinal care. Genentech Clinical Trials is a resource with information in clear and understandable language about clinical trials where Roche/Genentech is doing or supporting research. A study to evaluate the efficacy and safety of gantenerumab in amyloid-positive, c Find out more about the clinical trial for Solid Tumors. Our R&D activities are focused on applying excellent science to discover and develop potential new medicines with the goal of becoming first-in-class or best-in-class therapeutics. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. This study aims to evaluate the safety, tolerability, immunogenicity, pharmacokinetics, a. is hiring a Senior Medical Director, Product Development, CVRM, with an estimated salary of $231,500 - $430,250. Learn more about our new molecular entities (NMES) in active clinical development. This resource is intended for patients, their relatives, caregivers or doctors. Find out more about the clinical trial for Alzheimer's Disease (AD). Rigorous and groundbreaking science has always been at the core of what we do at Genentech. The FDA and medical experts agree that the best way for patients to obtain access to medicines before they are approved in the United States is through participation in a clinical trial. This job in Pharmaceuticals & Biotech is in Boston, MA. Access the clinical trial testing the safety, tolerability, pharmacokinetics, immunogenicity, pharmacodynamics, and preliminary efficacy of RO7428731 in patien Access the clinical trial testing the tolerability, pharmacokinetics, anti-tumor activity and safety of multiple immunotherapy-based treatment combinations in Find information on SKYGLO, an actively enrolling Phase III clinical trial evaluating glofitamab as a potential therapy for first-line in large B-cell lymphoma (LBCL). Responsible for budget management of PS&H activities in USMA, delivering Phase IIIb/IV studies, and strengthening Genentech's ability to execute clinical trials, especially for specific Genentech Feb. Competitors followed suit. Clinical trials for genentech The European Union Clinical Trials Register allows you to search for protocol and results information on: interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development EU This extension trial aims to test the long-term safety of astegolimab in combination with standard of care COPD treatment. It also covers the Vascular Malformations pipeline therapeutics assessment by product 18th Annual Outsourcing in Clinical Trials West Coast 2026 Creating a collaborative environment where pharma & biotech leaders can find solutions to current challenges through innovations and partnerships Experience: You bring 20+ years in research or the biotech industry, with progressively responsible experience in Gene Therapy or Biologics analytical development and at least 10 years in A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer Completed Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation Cardiac Allograft Vasculopathy United States Mateon Therapeutics Completed Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV) Polypoidal Choroidal Vasculopathy 18th Annual Outsourcing in Clinical Trials West Coast 2026 Creating a collaborative environment where pharma & biotech leaders can find solutions to current challenges through innovations and partnerships The Clinical Demand & Supply Planning team ensures reliable, consistent, and cost-effective drug supply for clinical trials around the world for the global Roche/Genentech portfolio of >500 studies across Phase I–IV studies spanning multiple therapeutic areas and R&D partners (gRED, pRED, PD, PDMA, USMA) covering various drug modalities and Is Community Based Monitoring of Diabetic Maculopathy and Pre-proliferative Diabetic Retinopathy Safe? (FARSight-DM) Diabetes Mellitus | Diabetic Retinopathy | Diabetic Maculopathy United Kingdom Hawaii Pacific Health Genentech, Inc. 5 days ago · SOUTH SAN FRANCISCO, Calif. Completed A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma Chronic Lymphocytic Leukemia | Non-Hodgkins Genentech, a member of the Roche Group, announced today that the U. S. Help Your Patients Genentech Access Solutions offers your patients coverage support, assistance, other useful information. This study will evaluate the efficacy and safety of astegolima Access the clinical trial testing the safety, tolerability and efficacy of RO7017773 in patients aged 15-45 years with autism spectrum disorder. We believe that a broad spectrum of perspectives drive innovation and contribute towards health impacts for all. Dec 19, 2025 · Genentech media resources and info for stories in development. Food and Drug Administration (FDA) has accepted the company's New Drug Application for DelveInsight’s “Vascular Malformations Pipeline Insight, 2026” report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in the Vascular Malformations pipeline landscape. 4, revealed that 141 employees were laid off across the pharma’s operations. The purpose of the study is to evaluate glofitamab + gemcitabine + oxaliplatin in participants in th Find out more about the clinical trial for Acute Ischemic Stroke, Thrombolysis. New drugs are first studied in a laboratory, and those that look promising go on to be carefully studied in people through clinical trials Find information on AMETRINE-2, an actively enrolling Phase III clinical trial evaluating afimkibart as a potential therapy for Ulcerative Colitis (UC). People can take part if they have completed a year of treatment with astegolimab or placebo in one of the two parent trials. GA28949 Access the clinical trial testing the efficacy and safety of etrolizumab compared with adalimumab in patients with moderate to severe ulcerative coliti The clinical trials and molecule information included represent only a subset of the Roche/Genentech pipeline, specifically highlighting a selection of investigational molecules involved in actively recruiting Phase 3 trials. GA28949 Access the clinical trial testing the efficacy and safety of etrolizumab compared with adalimumab in patients with moderate to severe ulcerative coliti Find out more about the clinical trial for Multiple Sclerosis (MS). The clinical trials and molecule information included represent only a subset of the Roche/Genentech pipeline, specifically highlighting a selection of investigational molecules involved in actively recruiting Phase 3 trials. Find important safety information and patient resources for all of our currently marketed medicines. Easy 1-Click Apply Genentech Enterprise Clinical Service Provider Lead (IxRS) Full-Time job opening hiring now in South San Francisco, CA. Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U. Clinical Trials Proposed Mechanism of Action Unlike the endogenous GLP-1 hormone, CT-996 is specifically designed to be a biased agonist that activates cAMP signaling with minimal-to- no beta-arrestin recruitment. This study will evaluate the efficacy and safety of tenecteplase compared with Discover the study to investigate faricimab (RO6867461) treatment response in treatment-naive, underrepresented patients with diabetic macular edema (DME). A Worker Adjustment and Retraining Notification (WARN) alert from the state of California, posted Feb. Find recent and archived press releases. -- (BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from CT388-103, a Phase II clinical 5 days ago · Genentech, a subsidiary of Roche, launched dozens of clinical trials. Clinical Program Leader at Genentech Giredestrant has an extensive clinical development program and is being investigated in five company-sponsored Phase III clinical trials that span multiple treatment settings and lines of therapy There is an urgent need for more effective treatments that can delay clinical progression and reduce the burden of treatment on people’s lives. Access the phase 3 registrational clinical trial for giredestrant combined with CDK4/6 inhibitor (palbociclib, ribociclib or abemaciclib) as first-line treatme Access the clinical trial testing the safety, tolerability, pharmacokinetics, immunogenicity, pharmacodynamics, and preliminary efficacy of RO7428731 in patien Find out more about the clinical trial for Alzheimer's Disease (AD). Jan 20, 2026 · Founded 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. Genentech, Inc. Find out how Genentech is advancing inclusive research and health equity for all patients. Completed Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) (PEARL) Polypoidal Choroidal Vasculopathy United States Southeast Retina Center, Georgia Experience: You bring 20+ years in research or the biotech industry, with progressively responsible experience in Gene Therapy or Biologics analytical development and at least 10 years in A Clinical Trial to Investigate the Safety and Efficacy of Papillex® on Abnormal Cervical Cells Caused by HPV. Apply now! Clinical Trial Information Clinical trials are research studies that are designed to determine if a medicine is safe and effective for patients. Recruiting A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial) Idiopathic Pulmonary Fibrosis | Progressive Fibrosing Interstitial Lung Disease Canada, France, United Kingdom, Belgium, Australia, Germany, Italy, New Zealand, Mexico, Austria, Argentina, Malaysia, Ireland, South Korea Scleroderma Research Foundation, Inc. shhz, ki07b, kvsdz0, ug6iod, cl6x, wsyva, qnnl2, rlqtms, cfws, f5hk,